Home
About
Curriculum
First Year Requirements
Second Year Requirements
Advanced Year Requirements
Professional Development
MD/PhD Requirements
Student Testimonials
The University
Photo Galleries
Recent Accomplishments
Recent Publications
People
Faculty
Students
Alumni
Admissions
How To Apply
FAQ
Living in Baltimore
News
News
Calendar
Upcoming Events
Resources
Diversity & Inclusion
BCMB Diversity, Equity, Inclusion Committee
Diversity Resources for Current Students
Accommodations
Contact Us
Menu
Kyle Rhodehouse
Home
Kyle Rhodehouse
Kyle Rhodehouse
krhodeh1@jhmi.edu
BA, Colgate University
Thesis Lab:
Siliciano Lab
Associated BCMB Faculty Member(s)
Name
Lab Website
Robert Siliciano
Lab website
Publications
McMyn NF, Varriale J,
Fray EJ
, Zitzmann C, MacLeod H, Lai J, Singhal A,
Moskovljevic M
, Garcia MA, Lopez BM, Hariharan V,
Rhodehouse K
, Lynn K, Tebas P, Mounzer K, Montaner LJ, Benko E, Kovacs C, Hoh R, Simonetti FR, Laird GM, Deeks SG, Ribeiro RM, Perelson AS, Siliciano RF, Siliciano JM., 2023, The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy, J Clin Invest., 133(17):e171554. doi: 10.1172/JCI171554. PMCID: PMC10471168
PubMed
White JA, Wu F, Yasin S,
Moskovljevic M
, Varriale J, Dragoni F, Camilo-Contreras A, Duan J, Zheng MY, Tadzong NF, Patel HB, Quiambao JMC,
Rhodehouse K
, Zhang H, Lai J, Beg SA, Delannoy M, Kilcrease C, Hoffmann CJ, Poulin S, Chano F, Tremblay C, Cherian J, Barditch-Crovo P, Chida N, Moore RD, Summers MF, Siliciano RF, Siliciano JD, Simonetti FR., 2023, Clonally expanded HIV-1 proviruses with 5'-leader defects can give rise to nonsuppressible residual viremia, J Clin Invest., 133(6):e165245. doi: 10.1172/JCI165245. PMCID: PMC10014112
PubMed
Simonetti FR, Zhang H, Soroosh GP, Duan J,
Rhodehouse K
, Hill AL, Beg SA, McCormick K, Raymond HE, Nobles CL, Everett JK, Kwon KJ, White JA, Lai J, Margolick JB, Hoh R, Deeks SG, Bushman FD, Siliciano JD, Siliciano RF., 2021, Antigen-driven clonal selection shapes the persistence of HIV-1-infected CD4+ T cells in vivo, J Clin Invest., 131(3):e145254. doi: 10.1172/JCI145254. PMCID: PMC7843227.
PubMed